antineoplastic agents, phytogenic

Preferred Label : antineoplastic agents, phytogenic;

MeSH definition : Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity.;

MeSH synonym : phytogenic antineoplastic agents; botanical antineoplastics; antineoplastics, phytogenic; phytogenic antineoplastics; agents, phytogenic antineoplastic; antineoplastics, botanical;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D000972;

UMLS CUI

C0003394;

ATC code(s)
- colchicine derivatives [ATC Code]
- paclitaxel [ATC Code]
- podophyllotoxin derivatives [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Indexing information
- (2-methyl-n-butyl)shikonin [MeSH Supplementary Concept]
- (25S)-ruscogenin 1-sulfate-3-O-alpha-L-rhamnopyranoside [MeSH Supplementary Concept]
- (2R)-4'-hydroxy-2',5,7-trimethoxyflavane [MeSH Supplementary Concept]
- (2R,4R)-2',4'-dihydroxy-5,7-dimethoxyflavan-4-ol [MeSH Supplementary Concept]
- (2S,3S)-sulfated pterosin C [MeSH Supplementary Concept]
- (3R)-3,5-bis(3-methoxy-4-hydroxyphenyl)-2,3-dihydro-2(1H)-pyridinone [MeSH Supplementary Concept]
- (4S)-4-isopropylcyclohex-l-enecarboxylic acid 4-O-beta-D-glucopyranoside [MeSH Supplementary Concept]
- (7R,8S)-7-hydroxy-8-ethoxyrutaecarpine [MeSH Supplementary Concept]
- (7R,8S)-7-hydroxy-8-methoxyrutaecarpine [MeSH Supplementary Concept]
- (8R)-3beta,8-dihydroxypolypoda-13E,17E,21-triene [MeSH Supplementary Concept]
- (Z)-cryptomoscatone D2 [MeSH Supplementary Concept]
- 1,3,6,7-tetrahydroxyxanthone [MeSH Supplementary Concept]
- 1,5-dimethyl-6-phenyl-1,2-dihydro-1,2,4-triazin-3(2H)-one [MeSH Supplementary Concept]
- 1,6-dimethoxy-3-methyl-2-naphthoic acid [MeSH Supplementary Concept]
- 1-(4'-hydroxyphenyl)-3-hydroxy-5-phenyl-1,5-pentandione [MeSH Supplementary Concept]
- 10-deacetoxypaclitaxel [MeSH Supplementary Concept]
- 11alpha,12alpha-epoxy-3-O-beta-D-xylopyranosyl-(1-3)-alpha-L-rhamnopyranosyl-(1-2)-beta-D-xylopyranosyl-olean-28,13beta-olide [MeSH Supplementary Concept]
- 11alpha,12alpha-epoxy-3-O-beta-D-xylopyranosyl-olean-28,13beta-olide [MeSH Supplementary Concept]
- 11alpha-hydroxypimara-8(14),15-diene [MeSH Supplementary Concept]
- 1beta,11alpha-dihydroxypimara-8(14),15-diene [MeSH Supplementary Concept]
- 2''-cysteinyl-epigallocatechin-3-gallate [MeSH Supplementary Concept]
- 2'-cysteinyl-epigallocatechin-3-gallate [MeSH Supplementary Concept]
- 2'-hydroxy-4',5'-dimethoxychalcone [MeSH Supplementary Concept]
- 2,9-dihydroxy-4,7-megastigmadiene-3-O-beta-glucoside [MeSH Supplementary Concept]
- 2-methoxyjuglone [MeSH Supplementary Concept]
- 25-methoxylprotopanaxadiol [MeSH Supplementary Concept]
- 3-O-D-xylopyranosyl-(1-3)-alpha-L-rhamnopyranosyl-(1-2)-beta-D-xylopyranosyl oleanolic acid 28-O-beta-D-glucopyranoside [MeSH Supplementary Concept]
- 3-O-alpha-L-rhamnopyranosyl-(1-2)-(beta-D-glucopyranosyl-(1-4))-alpha-L-arabinopyranosyl siaresinolic acid 28-O-alpha-L-rhamnopyranosyl-(1-4)-beta-D-glucopyranosyl-(1-6)-beta-D-glucopyranosyl ester [MeSH Supplementary Concept]
- 3-O-beta-D-glucopyranosyl(1-4)-beta-D-fucopyranosyl-(22S,24Z)-cycloart-24-en-3beta,22,26,29-tetraol 26-O-beta-D-glucopyranoside [MeSH Supplementary Concept]
- 3-O-beta-D-glucopyranosyl(1-4)-beta-D-fucopyranosyl-(22S,24Z)-cycloart-24-en-3beta,22,26,30-tetraol 26-O-beta-D-glucopyranoside [MeSH Supplementary Concept]
- 3-O-beta-D-glucopyranosyl-(1-3)-beta-D-xylopyranosyl-(1-2)-(alpha-L-rhamnopyranosyl-(1-3))-beta-D-glucopyranosyl-(1-4)-(beta-D-glucopyranosyl-(1-2))-alpha-L-arabinopyranosyl-3beta,16alpha,28,30-tetrahydroxy-olean-12-ene [MeSH Supplementary Concept]
- 3-methoxyapigeninidin [MeSH Supplementary Concept]
- 3beta,16-dihydroxy-25-hydroperoxytirucalla-7,23(24)-dien-6-oxo acid [MeSH Supplementary Concept]
- 3beta,16beta-hydroxytirucalla-7,24(25)-dien-21,23-olide [MeSH Supplementary Concept]
- 3beta,16beta-hydroxytirucalla-7,24(25)-dien-6-oxo-21,23-olide [MeSH Supplementary Concept]
- 3beta,19alpha,23-trihydroxy-20alpha(H)-urs-12-en-28-oic acid 3beta-O-alpha-L-arabinopyranoside [MeSH Supplementary Concept]
- 3beta,23-dihydroxy-20alpha(H)-urs-12-en-28-oic acid [MeSH Supplementary Concept]
- 4'-methoxy licoflavanone [MeSH Supplementary Concept]
- 4,6-dimethoxy-2,5-quinodihydrochalcone [MeSH Supplementary Concept]
- 4,7-dimethoxyl-5-formyl-6-hydroxycoumarin [MeSH Supplementary Concept]
- 4,7-dimethoxyl-5-methyl-6-hydroxycoumarin [MeSH Supplementary Concept]
- 5,7-dihydroxy-2-(1,2-isopropyldioxy-4-oxo-cyclohex-5-enyl)-chromen-4-one [MeSH Supplementary Concept]
- 5-hydroxylpiperlongumine [MeSH Supplementary Concept]
- 6'-hydroxyjusticidin A [MeSH Supplementary Concept]
- 6-O-beta-D-glucopyranosyl-20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol-3-one [MeSH Supplementary Concept]
- 6-hydroxysalvinolone [MeSH Supplementary Concept]
- 6-prenylapigenin [MeSH Supplementary Concept]
- 7-hydroxylsolajiangxin I [MeSH Supplementary Concept]
- 7-hydroxynoracronycine [MeSH Supplementary Concept]
- 7beta,11alpha-dihydroxypimara-8(14),15-diene [MeSH Supplementary Concept]
- CF31 xanthone [MeSH Supplementary Concept]
- GP 7 [MeSH Supplementary Concept]
- Granulins [MeSH Descriptor]
- S-allylmercaptocysteine [MeSH Supplementary Concept]
- ainsliadimer B [MeSH Supplementary Concept]
- angustifonine A [MeSH Supplementary Concept]
- angustifonine B [MeSH Supplementary Concept]
- astrotricoumarin [MeSH Supplementary Concept]
- berberine alpha-hydroxy-beta-decanoylethyl sulfonate [MeSH Supplementary Concept]
- biflorin [MeSH Supplementary Concept]
- broussoflavonol B [MeSH Supplementary Concept]
- cephalancetine A [MeSH Supplementary Concept]
- cephalancetine B [MeSH Supplementary Concept]
- cephalancetine C [MeSH Supplementary Concept]
- citriolide A [MeSH Supplementary Concept]
- conyzapyranone A [MeSH Supplementary Concept]
- conyzapyranone B [MeSH Supplementary Concept]
- coronopilin [MeSH Supplementary Concept]
- cucurbitacin E 2-O-beta-D-glucopyranoside [MeSH Supplementary Concept]
- cylindroside A [MeSH Supplementary Concept]
- daphneolone-4'-O-beta-D-glucoside [MeSH Supplementary Concept]
- dioscorolide A [MeSH Supplementary Concept]
- dioscorolide B [MeSH Supplementary Concept]
- diplotasin [MeSH Supplementary Concept]
- diplotrin A [MeSH Supplementary Concept]
- diplotrin B [MeSH Supplementary Concept]
- diplotrin C [MeSH Supplementary Concept]
- ent-11alpha-hydroxy-15-oxo-kaur-16-en-19-oic-acid [MeSH Supplementary Concept]
- ergosterol 3-O-beta-D-galactopyranoside [MeSH Supplementary Concept]
- ergosterol 3-O-beta-D-glucopyranoside [MeSH Supplementary Concept]
- feruhodin A [MeSH Supplementary Concept]
- feruhodin B [MeSH Supplementary Concept]
- formosanin C [MeSH Supplementary Concept]
- gancaonin Q [MeSH Supplementary Concept]
- garcimangostanol [MeSH Supplementary Concept]
- glutinosalactone C [MeSH Supplementary Concept]
- gochnatiolide A [MeSH Supplementary Concept]
- gochnatiolide B [MeSH Supplementary Concept]
- heterogenoside E [MeSH Supplementary Concept]
- heterogenoside F [MeSH Supplementary Concept]
- honatisine [MeSH Supplementary Concept]
- isoabietenin A [MeSH Supplementary Concept]
- isoabietenin B [MeSH Supplementary Concept]
- isoabietenin C [MeSH Supplementary Concept]
- isocorydione [MeSH Supplementary Concept]
- isorosthin A [MeSH Supplementary Concept]
- jatrophaeudesmene C [MeSH Supplementary Concept]
- juglanthraquinone C [MeSH Supplementary Concept]
- kalantubolide A [MeSH Supplementary Concept]
- kalantubolide B [MeSH Supplementary Concept]
- lepidotrichilin A [MeSH Supplementary Concept]
- lepidotrichilin B [MeSH Supplementary Concept]
- ligraminol A [MeSH Supplementary Concept]
- longikaurin A [MeSH Supplementary Concept]
- lunularic acid 4'-glucoside [MeSH Supplementary Concept]
- methyltanshinoate [MeSH Supplementary Concept]
- millepachine [MeSH Supplementary Concept]
- millettinol [MeSH Supplementary Concept]
- mollipilin A [MeSH Supplementary Concept]
- mollipilin B [MeSH Supplementary Concept]
- mulberrofuran F1 [MeSH Supplementary Concept]
- nigrofomin A [MeSH Supplementary Concept]
- nigrofomin B [MeSH Supplementary Concept]
- oleanolic acid 3-O-alpha-L-rhamnopyranosyl-(1-2)-(beta-D-glucopyranosyl-(1-4))-alpha-L-arabinopyranoside [MeSH Supplementary Concept]
- polyphyllin D [MeSH Supplementary Concept]
- proliferin A [MeSH Supplementary Concept]
- pseudolaridimer B [MeSH Supplementary Concept]
- quercetin 7-O-6''-(E-caffeoyl)-beta-D-glucopyranoside [MeSH Supplementary Concept]
- reevesioside F [MeSH Supplementary Concept]
- rubescensin S [MeSH Supplementary Concept]
- rugosachromenone A [MeSH Supplementary Concept]
- saxifragifolin D [MeSH Supplementary Concept]
- schomburgbiphenyl A [MeSH Supplementary Concept]
- schomburgbiphenyl B [MeSH Supplementary Concept]
- scutebata P [MeSH Supplementary Concept]
- scutebata Q [MeSH Supplementary Concept]
- solajiangxin A [MeSH Supplementary Concept]
- solajiangxin B [MeSH Supplementary Concept]
- solajiangxin C [MeSH Supplementary Concept]
- solajiangxin H [MeSH Supplementary Concept]
- solajiangxin I [MeSH Supplementary Concept]
- syreiteate A [MeSH Supplementary Concept]
- syreiteate B [MeSH Supplementary Concept]
- tabernaelegantine B [MeSH Supplementary Concept]
- tabernaelegantine D [MeSH Supplementary Concept]
- tas41 compound [MeSH Supplementary Concept]
- toxicarioside A [MeSH Supplementary Concept]
- trametenolic acid B [MeSH Supplementary Concept]
- trans-avicennol [MeSH Supplementary Concept]
- trigohowilol E [MeSH Supplementary Concept]
- trigohowilol F [MeSH Supplementary Concept]
- tupisteroide C [MeSH Supplementary Concept]
- urgineanin A [MeSH Supplementary Concept]
- vernomelitensin [MeSH Supplementary Concept]
- vernopicrin [MeSH Supplementary Concept]
- xylomexicanin C [MeSH Supplementary Concept]
Ne pas confondre avec
- anticarcinogenic agents [MeSH Descriptor]
Record concept(s)
- antineoplastic agents, phytogenic [MeSH concept]
See also (suggested by CISMeF)
- phytotherapy [MeSH Descriptor]
- plants, medicinal [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 10-hydroxycamptothecin [MeSH Supplementary Concept]
- GEL protein, gelonium multiflorum [MeSH Supplementary Concept]
- Homoharringtonine [MeSH Descriptor]
- MMC protein, momordica charantia [MeSH Supplementary Concept]
- Resveratrol [MeSH Descriptor]
- Silybin [MeSH Descriptor]
- Ursolic Acid [MeSH Descriptor]
- Vinorelbine [MeSH Descriptor]
- Weijing decoction [MeSH Supplementary Concept]
- acronine [MeSH Descriptor]
- acteoside [MeSH Supplementary Concept]
- amygdalin [MeSH Descriptor]
- beta-thujaplicin [MeSH Supplementary Concept]
- bivatuzumab mertansine [MeSH Supplementary Concept]
- bullatacin [MeSH Supplementary Concept]
- camptothecin [MeSH Descriptor]
- cantuzumab mertansine [MeSH Supplementary Concept]
- carvone [MeSH Supplementary Concept]
- cepharanthine [MeSH Supplementary Concept]
- cinnamaldehyde [MeSH Supplementary Concept]
- combretastatin [MeSH Supplementary Concept]
- costunolide [MeSH Supplementary Concept]
- demecolcine [MeSH Descriptor]
- ellipticines [MeSH Descriptor]
- epicatechin gallate [MeSH Supplementary Concept]
- etoposide [MeSH Descriptor]
- fagaronine [MeSH Supplementary Concept]
- fosbretabulin [MeSH Supplementary Concept]
- ginsenoside Rg3 [MeSH Supplementary Concept]
- glaucarubin [MeSH Descriptor]
- gossypol acetic acid [MeSH Supplementary Concept]
- grape seed extract [MeSH Descriptor]
- harringtonines [MeSH Descriptor]
- helenalin [MeSH Supplementary Concept]
- herbal preparation PC-SPES [MeSH Supplementary Concept]
- honokiol [MeSH Supplementary Concept]
- indicine-N-oxide [MeSH Supplementary Concept]
- lapachol [MeSH Supplementary Concept]
- lorvotuzumab mertansine [MeSH Supplementary Concept]
- maytansine [MeSH Descriptor]
- mezerein [MeSH Supplementary Concept]
- muconomycin A [MeSH Supplementary Concept]
- namitecan [MeSH Supplementary Concept]
- paclitaxel [MeSH Descriptor]
- plumbagin [MeSH Supplementary Concept]
- podophyllin [MeSH Descriptor]
- podophyllotoxin [MeSH Descriptor]
- retrorsine [MeSH Supplementary Concept]
- saikosaponin D [MeSH Supplementary Concept]
- senecionine [MeSH Supplementary Concept]
- sizofiran [MeSH Descriptor]
- swainsonine [MeSH Descriptor]
- tanshinone [MeSH Supplementary Concept]
- tetrandrine [MeSH Supplementary Concept]
- tingenone [MeSH Supplementary Concept]
- trichosanthin [MeSH Descriptor]
- tupichinin A [MeSH Supplementary Concept]
- tupichinolide [MeSH Supplementary Concept]
- ursolic acid [MeSH Supplementary Concept]
- vinblastine [MeSH Descriptor]
- vincristine [MeSH Descriptor]
- vindesine [MeSH Descriptor]
- xanthatin [MeSH Supplementary Concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients